MacroGenics

$39.5M revenue • 201 employees • United States

Company Overview

Company Name

MacroGenics

Address

United States

Approx. Annual Revenue

$39.5M

Employees

201

About MacroGenics

MacroGenics is a biopharmaceutical company based in the United States that focuses on developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The company has approximately 201 employees and is developing a broad pipeline of investigational product candidates, including those targeting B7-H3, PD-1, LAG-3, and CD123, to address unmet medical needs.

Frequently Asked Questions about MacroGenics

Technologies Used

Key Decision Makers

Jacin Hayes, PMP Senior Manufacturing Outsourcing Manager
LinkedIn
Janine Koucheki Associate Director Clinical Operations
LinkedIn
Ashley Flynn Ward, MD Vice President, Clinical Development
LinkedIn